TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE

Rhea-AI Summary

The Italian Trade Agency (ITA) hosted the eighth edition of 'Italy on the Move' during the 43rd J.P. Morgan Healthcare Conference 2025, attracting over 230 executives and investors. The event highlighted investment opportunities in Italy's €270 Billion life sciences sector. Director General Mauro Battocchi presented Italy's achievements, including €2 billion in pharma R&D investments in 2023 and an average life expectancy of 83.8 years.

The event featured a panel discussion titled 'Navigating Transatlantic Partnerships in Life Sciences,' moderated by Audrey Greenberg, with participation from prominent executives including leaders from Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, Genenta Science, ENEA Tech and Biomedical, and DOC Pharma. Five Italian startups also pitched their innovations: Aavantgarde, Butterfly Decisions, Cellply, Medlea, and Sibylla Biotech.

Positive

• Italy's life sciences sector valued at €270 Billion
• €2 billion invested in pharma R&D in 2023

Negative

• None.

News Market Reaction – GNTA

-0.24%

1 alert

-0.24% News Effect

On the day this news was published, GNTA declined 0.24%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

• Over 230 Italian and U.S. executives, Italian government leaders, and investors attended the eighth edition of "Italy On the Move"
• Seven life sciences executives provided business insights during "Navigating Transatlantic Partnerships in Life Sciences" panel discussion and five Italian startups pitched their unique breakthroughs and investment opportunities
• Director General for the Promotion of Italy Mauro Battocchi discussed private and public/institutional financial opportunities in the €270 Billion Italian life sciences sector¹

SAN FRANCISCO, Jan. 28, 2025 /PRNewswire/ -- The Italian Trade Agency (ITA) collaborated with the Ministry of Foreign Affairs and International Cooperation to host the eighth edition of "Italy on the Move," a side event during the 43^rd annual J.P. Morgan Healthcare Conference 2025 at INNOVIT - The Italian Innovation and Culture Hub. The event showcased investment opportunities in Italy in 2025 and included over 230 Italian and U.S. executives, Italian government leaders, members of the scientific and academic world, and investors.

As presented by Mauro Battocchi, Director General for the Promotion of Italy at the Ministry of Foreign Affairs and International Cooperation, following decades of investment by the Italian government in public health, which helped increase the average life expectancy of Italian citizens to 83.8 years and fueled the growth of life sciences businesses in Italy by providing more than € 2 billion on pharma R&D investments in 2023, Italy is now a global leader in life sciences.

The following leaders shared their unique perspectives on investing in Italy during the panel discussion, "Navigating Transatlantic Partnerships in Life Sciences," which was moderated by Audrey Greenberg, Founder of the Center for Breakthrough Medicines and CEO and Founder of AG Capital Advisors.

• Frederick Beddingfield - CEO, Rubedo Life Sciences
• Fulvio Renoldi Bracco - Vice Chairman and CEO, Bracco Imaging
• Elcin Barker Ergun - CEO and Member of the Board, Menarini Group
• Karthic Jayaraman - Partner and Co-Head of Global Healthcare, TPG Capital
• Pierluigi Paracchi - CEO, Co-Founder and Chairman, Genenta Science (Nasdaq: GNTA)
• Maria Cristina Porta - General Director, ENEA Tech and Biomedical
• Riccardo Zagaria - CEO, DOC Pharma

To learn more about the five Italian startups featured in the program, visit their respective websites included below.

• Aavantgarde
• Butterfly Decisions
• Cellply
• Medlea
• Sibylla Biotech

Trade Commissioner Giosafat Riganò expressed his enthusiasm for the success of Italy on The Move 2025, stating: "Thanks to the exceptional efforts of the Italian Trade Agency Team, we witnessed outstanding participation, with over 230 attendees, including U.S. and Italian industry experts, confirming the significant international interest in the Italian Life Sciences industry."

Contact for Future Events and Collaborations:
Italian Trade Agency – Los Angeles Office
losangeles@ice.it

About the Italian Trade Agency 
The Italian Trade Agency is the government agency which promotes the globalization of Italian firms under the aegis of the Ministry of Foreign Affairs. ITA helps to develop, facilitate and promote Italian economic and trade relations with foreign countries, focusing on the needs of SMEs, their associations and partnerships. ITA sustains Italian firms in their internationalization process, promoting the marketing of Italian goods and services as well as the image of "Made in Italy" products around the world, while facilitating outward Italian investments and encouraging FDI attraction into Italy. ITA's headquarters are based in Rome, and it works through a large network of offices around the world which are acknowledged as "Trade Promotion Offices" of the Embassies or Consulates of Italy. https://www.ice.it/en/

LinkedIn: https://www.linkedin.com/company/italosangeles/
Twitter: https://twitter.com/ITALosAngeles
Facebook: https://www.facebook.com/italosangeles

About INNOVIT
The Italian Innovation and Culture Hub INNOVIT is a strategic initiative of the Italian Government for the promotion of the Country System's innovation in the United States. Its mission is to foster the Italian innovative companies, startups and tech ecosystems by connecting them with the Silicon Valley and US ones.
Web: innovitsf.com
LinkedIn: innovitsf

¹Assolombarda. (2024, July). La rilevanza della filiera Life Science in Lombardia https://www.assolombarda.it/centro-studi/la-rilevanza-della-filiera-life-science-in-lombardia-edizione-2024 Accessed 1 January 2024.

View original content to download multimedia:https://www.prnewswire.com/news-releases/top-italian-and-us-life-sciences-executives-and-italian-government-leaders-shared-business-success-stories-with-investors-at-italy-on-the-move-2025-side-event-during-jp-morgan-healthcare-conference-302361963.html

SOURCE Italian Trade Agency

FAQ

What was the total investment in Italian pharma R&D for 2023?

According to the presentation at Italy on the Move 2025, Italy invested more than €2 billion in pharmaceutical R&D during 2023.

How large is Italy's life sciences sector in 2025?

Italy's life sciences sector is valued at €270 Billion, as presented during the Italy on the Move 2025 event.

How many attendees participated in Italy on the Move 2025?

Over 230 Italian and U.S. executives, government leaders, and investors attended the eighth edition of Italy on the Move 2025.

Which companies participated in the Transatlantic Partnerships panel at Italy on the Move 2025?

The panel included executives from Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, Genenta Science (GNTA), ENEA Tech and Biomedical, and DOC Pharma.